MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 60 filers reported holding MEI PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $62,000 | -35.4% | 38,590 | 0.0% | 0.04% | 0.0% |
| Q4 2019 | $96,000 | +47.7% | 38,590 | 0.0% | 0.04% | +44.4% |
| Q3 2019 | $65,000 | -32.3% | 38,590 | 0.0% | 0.03% | -32.5% |
| Q2 2019 | $96,000 | -18.6% | 38,590 | 0.0% | 0.04% | -14.9% |
| Q1 2019 | $118,000 | +15.7% | 38,590 | 0.0% | 0.05% | -2.1% |
| Q4 2018 | $102,000 | +12.1% | 38,590 | +83.8% | 0.05% | +60.0% |
| Q3 2018 | $91,000 | +9.6% | 21,000 | 0.0% | 0.03% | -3.2% |
| Q2 2018 | $83,000 | +186.2% | 21,000 | +50.0% | 0.03% | +158.3% |
| Q1 2018 | $29,000 | 0.0% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $29,000 | -23.7% | 14,000 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $38,000 | – | 14,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |